Today’s Stock Market in 2-Minutes
June 11, 2026
Genprex Announces First Patient Dosed in Phase 1/2 Acclaim-1 Clinical Trial of REQORSA(TM) Immunogene Therapy in Combination with Tagrisso® to Treat Non-Small Cell Lung Cancer
March 2, 2022
Related Post
-
-
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
June 11, 2026
-
American Oncology Network and CanCare, Inc. Announce Partnership to Provide Whole-Person Cancer Care, Combining Physical and Emotional Support for Patients Nationwide
June 11, 2026
-
Teads Launches its AI-Driven Operating System, Teads EngageOS, to Maximize Publisher Total Revenue
June 11, 2026